Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Massa

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 2013
Fast dendritic cells stimulated with alternative maturation mixtures induce polyfunctional and long-lasting activation of innate and adaptive effector cells with tumor-killing capabilitiesChiara Massa, Barbara Seliger
Cellular Immunology|December 19, 2017
The tumor microenvironment: Thousand obstacles for effector T cellsChiara Massa, Barbara Seliger
Cancers|February 4, 2021
Immune Therapy Resistance and Immune Escape of TumorsBarbara Seliger, Chiara Massa
Frontiers in Immunology|June 6, 2022
Modulation of Lymphocyte Functions in the Microenvironment by Tumor Oncogenic PathwaysBarbara Seliger, Chiara Massa
Frontiers in Immunology|October 13, 2023
Combination of multiple omics techniques for a personalized therapy or treatment selectionChiara Massa, Barbara Seliger
Frontiers in Immunology|December 19, 2013
The dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escapeBarbara Seliger, Chiara Massa
Journal of Translational Medicine|July 2, 2025
CyTOF as a suitable tool for stratification and monitoring of cancer patientsBarbara Seliger, Chiara Massa
Cancer Immunology, Immunotherapy : CII|February 7, 2020
"Tumor immunology meets oncology (TIMO) XV", April 25th-27th 2019, Halle/Saale, GermanyAndré Steven, Chiara Massa, Barbara Seliger
Cancer Research|September 6, 2005
Chaperon and adjuvant activity of hsp70: different natural killer requirement for cross-priming of chaperoned and bystander antigensChiara Massa, Cecilia Melani, Mario P Colombo
International Journal of Molecular Sciences|April 13, 2023
Interferons and Resistance Mechanisms in Tumors and Pathogen-Driven Diseases-Focus on the Major Histocompatibility Complex (MHC) Antigen Processing PathwayChiara Massa, Yuan Wang, Nico Marr, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 2013
Fast dendritic cells stimulated with alternative maturation mixtures induce polyfunctional and long-lasting activation of innate and adaptive effector cells with tumor-killing capabilitiesChiara Massa, Barbara Seliger
Cellular Immunology|December 19, 2017
The tumor microenvironment: Thousand obstacles for effector T cellsChiara Massa, Barbara Seliger
Cancers|February 4, 2021
Immune Therapy Resistance and Immune Escape of TumorsBarbara Seliger, Chiara Massa
Frontiers in Immunology|June 6, 2022
Modulation of Lymphocyte Functions in the Microenvironment by Tumor Oncogenic PathwaysBarbara Seliger, Chiara Massa
Frontiers in Immunology|October 13, 2023
Combination of multiple omics techniques for a personalized therapy or treatment selectionChiara Massa, Barbara Seliger
Frontiers in Immunology|December 19, 2013
The dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escapeBarbara Seliger, Chiara Massa
Journal of Translational Medicine|July 2, 2025
CyTOF as a suitable tool for stratification and monitoring of cancer patientsBarbara Seliger, Chiara Massa
Cancer Immunology, Immunotherapy : CII|February 7, 2020
"Tumor immunology meets oncology (TIMO) XV", April 25th-27th 2019, Halle/Saale, GermanyAndré Steven, Chiara Massa, Barbara Seliger
Cancer Research|September 6, 2005
Chaperon and adjuvant activity of hsp70: different natural killer requirement for cross-priming of chaperoned and bystander antigensChiara Massa, Cecilia Melani, Mario P Colombo
International Journal of Molecular Sciences|April 13, 2023
Interferons and Resistance Mechanisms in Tumors and Pathogen-Driven Diseases-Focus on the Major Histocompatibility Complex (MHC) Antigen Processing PathwayChiara Massa, Yuan Wang, Nico Marr, et al.
Pageof 5